Privacy
On-Device Dictation for Healthcare: Privacy Benefits and Compliance Responsibilities
July 10, 2026 · 6 min read
Clinical dictation can contain highly sensitive information. Processing core dictation on the workstation can reduce the number of systems that receive that content, but it is only one part of a responsible healthcare workflow.
What runs locally in VeloxWaves
VeloxWaves is designed to process core dictation audio and transcript text on the user's computer. Its local memory, embeddings, document workflow, translation, and local AI features are also designed around the same on-device content boundary.
That architecture can help a clinician avoid routing dictated content through a hosted transcription provider. Account, subscription, release, model-download, and optional support services remain separate product workflows. Our Trust & Privacy guide maps those paths in detail.
Why local processing is not a compliance claim
HIPAA obligations apply to covered entities and business associates. The U.S. Department of Health and Human Services explains that merely providing software does not automatically make a vendor a business associate when the vendor has no access to the customer's protected health information; the relationship must still be evaluated in context.
GDPR similarly involves more than product architecture: organizations must determine their role, lawful basis, transparency obligations, and appropriate technical and organizational measures. Health data receives additional protection under the GDPR.
For those reasons, VeloxWaves does not claim HIPAA or GDPR compliance, certification, or suitability for every clinical deployment.
Practical safeguards for individual clinicians
- Use a managed, access-controlled workstation and follow your organization's device-security requirements.
- Apply your organization's policy for where notes may be inserted, stored, exported, and retained.
- Review transcript output before placing it in a patient record or relying on it for care.
- Do not include patient information in support messages, screenshots, or log attachments; redact support material first.
- Ask your privacy, security, or compliance team to assess the complete workflow before handling regulated information.
Before an organization deploys at scale
Organizations should assess the product's data flows, endpoint controls, retention and deletion practices, support process, vendors, and any optional integrations. They should also determine whether contracts such as a business associate agreement or data processing agreement are required for their intended use.
That work is specific to the organization's role, policies, jurisdiction, and workflow. A local-first application can narrow a data path; it cannot make those decisions on the organization's behalf.
For a clearly labeled product vision about continuity across care shifts, read Shared Clinical Memory for Long-Term Care.
Sources and further reading
Want to understand the local-first product boundary before trying VeloxWaves?
Read the Trust & Privacy guide